A Surrey widow is suing a major pharmaceutical company after she claims a clinical drug trial led to the death of her husband.
Susan Goss of Cloverdale alleges in a notice of civil claim filed in BC Supreme Court that her husband died of cancer two years ago, after participating in a Pfizer drug trial to treat his chronic skin condition.
Goss says the drug–Xeljanz– is an immunosuppressant, which improved his psoriasis, but his hemoglobin readings dropped.
She alleges her husband, Trevor Goss, learned about the trial through an advertisement, and signed a consent order, but claims the company did not adequately disclose the risk of lymphoma.
Goss, who died at the age of 43, leaves behind two young children, and Goss is suing for negligence under the Family Compensation Act.
None of the allegations have been proven in court.
UPDATE on Friday, 1:30PM
Christina Antoniou with Pfizer Canada has since issued a response:
‘Pfizer Canada Inc. has not yet been served with the lawsuit and is not able to comment on the particulars of this claim. Xeljanz has been approved by Health Canada for use in patients with moderately to severely active rheumatoid arthritis. Xeljanz is a treatment option that has undergone extensive clinical testing over the course of its development. The Company works to ensure that individuals involved in its clinical trials are made aware of the benefits and risks of the clinical trial based on the existing scientific knowledge.’